Cleared Traditional

K213978 - TELIGEN System (FDA 510(k) Clearance)

Oct 2022
Decision
302d
Days
Class 2
Risk

K213978 is an FDA 510(k) clearance for the TELIGEN System. This device is classified as a Arthroscope (Class II - Special Controls, product code HRX).

Submitted by Medos International SARL (Lelocle, CH). The FDA issued a Cleared decision on October 18, 2022, 302 days after receiving the submission on December 20, 2021.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.1100. Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf)..

Submission Details

510(k) Number K213978 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 20, 2021
Decision Date October 18, 2022
Days to Decision 302 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code HRX — Arthroscope
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.1100
Definition Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).